Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079685956> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2079685956 endingPage "1164" @default.
- W2079685956 startingPage "1157" @default.
- W2079685956 abstract "1. The experimental antitumour agent meta-azidopyrimethamine is deactivated by reduction of the azide moiety to yield meta-aminopyrimethamine. This reaction was followed by h.p.l.c. subsequent to incubation of the drug with homogenates prepared from liver, kidney, spleen, intestine and heart of mice. Reducing activity was highest in liver homogenate and was time dependent. Following the incubation of 530 nmol meta-azidopyrimethamine with liver homogenate equivalent to 1 g liver for 30 min under air, 84% of the agent was reduced to meta-aminopyrimethamine. 2. Reducing activity was markedly lower in incubations containing subcellular fractions obtained from liver homogenate. Under aerobic conditions the 700 g and 12,500 g supernatant fractions were able to reduce 57% and 23%, respectively, of the amount of meta-azidopyrimethamine initially present. The respective pellets possessed weak reducing ability, but on reconstitution of the supernatants with their corresponding pellets most of the reducing activity as observed in the whole homogenate was recovered. 3. Microsomes and mitochondria reduced the drug only when incubations were performed in the presence of nitrogen but not under air. 4. A fraction of the reducing activity measured in the tissue homogenates was non-enzymatic, as heat-inactivated homogenates retained less than 10% of the activity exhibited by the untreated homogenates. Neither bovine serum albumin nor glutathione could reduce meta-azidopyrimethamine under the conditions of the tissue incubations, whereas dithiothreitol was a powerful reductant. The mixed enzymatic and non-enzymatic nature, the tissue distribution and the diffuse subcellular localisation of meta-azidopyrimethamine reducing activity resemble features of the bioreduction of N-oxides." @default.
- W2079685956 created "2016-06-24" @default.
- W2079685956 creator A5011033648 @default.
- W2079685956 creator A5027593342 @default.
- W2079685956 creator A5052049041 @default.
- W2079685956 date "1988-01-01" @default.
- W2079685956 modified "2023-09-26" @default.
- W2079685956 title "Medicinal Azides. Part 3. The Metabolism of the Investigational Antitumour Agent Meta-Azidopyrimethamine in Mouse Tissue<i>in vitro</i>" @default.
- W2079685956 cites W1970540527 @default.
- W2079685956 cites W1971566994 @default.
- W2079685956 cites W1979793602 @default.
- W2079685956 cites W2109728108 @default.
- W2079685956 cites W4300414728 @default.
- W2079685956 doi "https://doi.org/10.3109/00498258809042238" @default.
- W2079685956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3242311" @default.
- W2079685956 hasPublicationYear "1988" @default.
- W2079685956 type Work @default.
- W2079685956 sameAs 2079685956 @default.
- W2079685956 citedByCount "16" @default.
- W2079685956 countsByYear W20796859562012 @default.
- W2079685956 countsByYear W20796859562016 @default.
- W2079685956 countsByYear W20796859562020 @default.
- W2079685956 countsByYear W20796859562023 @default.
- W2079685956 crossrefType "journal-article" @default.
- W2079685956 hasAuthorship W2079685956A5011033648 @default.
- W2079685956 hasAuthorship W2079685956A5027593342 @default.
- W2079685956 hasAuthorship W2079685956A5052049041 @default.
- W2079685956 hasConcept C134018914 @default.
- W2079685956 hasConcept C153911025 @default.
- W2079685956 hasConcept C178790620 @default.
- W2079685956 hasConcept C181199279 @default.
- W2079685956 hasConcept C185592680 @default.
- W2079685956 hasConcept C186423591 @default.
- W2079685956 hasConcept C202751555 @default.
- W2079685956 hasConcept C25642318 @default.
- W2079685956 hasConcept C2777824588 @default.
- W2079685956 hasConcept C2780091579 @default.
- W2079685956 hasConcept C538909803 @default.
- W2079685956 hasConcept C55493867 @default.
- W2079685956 hasConcept C86803240 @default.
- W2079685956 hasConcept C86807702 @default.
- W2079685956 hasConcept C87644729 @default.
- W2079685956 hasConceptScore W2079685956C134018914 @default.
- W2079685956 hasConceptScore W2079685956C153911025 @default.
- W2079685956 hasConceptScore W2079685956C178790620 @default.
- W2079685956 hasConceptScore W2079685956C181199279 @default.
- W2079685956 hasConceptScore W2079685956C185592680 @default.
- W2079685956 hasConceptScore W2079685956C186423591 @default.
- W2079685956 hasConceptScore W2079685956C202751555 @default.
- W2079685956 hasConceptScore W2079685956C25642318 @default.
- W2079685956 hasConceptScore W2079685956C2777824588 @default.
- W2079685956 hasConceptScore W2079685956C2780091579 @default.
- W2079685956 hasConceptScore W2079685956C538909803 @default.
- W2079685956 hasConceptScore W2079685956C55493867 @default.
- W2079685956 hasConceptScore W2079685956C86803240 @default.
- W2079685956 hasConceptScore W2079685956C86807702 @default.
- W2079685956 hasConceptScore W2079685956C87644729 @default.
- W2079685956 hasIssue "10" @default.
- W2079685956 hasLocation W20796859561 @default.
- W2079685956 hasLocation W20796859562 @default.
- W2079685956 hasOpenAccess W2079685956 @default.
- W2079685956 hasPrimaryLocation W20796859561 @default.
- W2079685956 hasRelatedWork W1988064189 @default.
- W2079685956 hasRelatedWork W2025906826 @default.
- W2079685956 hasRelatedWork W2048692192 @default.
- W2079685956 hasRelatedWork W2089071106 @default.
- W2079685956 hasRelatedWork W2100379789 @default.
- W2079685956 hasRelatedWork W2167661898 @default.
- W2079685956 hasRelatedWork W2300046362 @default.
- W2079685956 hasRelatedWork W2314877183 @default.
- W2079685956 hasRelatedWork W2393822538 @default.
- W2079685956 hasRelatedWork W2413692821 @default.
- W2079685956 hasVolume "18" @default.
- W2079685956 isParatext "false" @default.
- W2079685956 isRetracted "false" @default.
- W2079685956 magId "2079685956" @default.
- W2079685956 workType "article" @default.